Delivery Order SPE2DR25D1053-SPE2DR26FT726
- Not listed
- The Defense Logistics Agency awarded a $1,223.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, a pharmaceutical product, with an ultimate completion date of October 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $1,184.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of November 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product, with final completion scheduled for August 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order valued at $3,670.77 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop in 10ml format, with an ultimate completion date of October 21, 2025. This competitive award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop in 10ML format, with completion scheduled for November 10, 2025. This non-competitive delivery order reflects a firm fixed-price contract structure and represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with the federal government. The award was issued on October 20, 2025, with performance to take place at the contractor's Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 25, 2025. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for XDEMVY 0.25% drop in 10ml format. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The delivery order is non-competitive, firm fixed-price in nature, and carries an ultimate completion date of October 30, 2025....
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for XDEMVY 0.25% drop in 10ml format, valued at $1,223.59 with a firm fixed price structure. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order is non-competitive...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT726Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,184.60 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop in 10ml format, with a firm fixed price and an ultimate completion date of December 2, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC contract serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and related medical commodities. This delivery order exemplifies the company's role in fulfilling routine federal medical supply requirements through the flexible contracting structure of the larger prime vendor agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/7/25 |